| R1 (Mild background retinopathy) |
19.6 |
76.8% (75.1–78.3) 2019/2630 |
611 |
80.0% (78.4–81.4) 2103/2630 |
527 |
80.4% (78.8–81.8) 2211/2751 |
540 |
| M1 (Observable maculopathy) |
0.9 |
96.6% (91.5–98.7) 112/116 |
4 |
94.0% (88.1–97.0) 109/116 |
7 |
94.4% (88.8–97.2) 117/124 |
7 |
| R2 (Observable background retinopathy) |
0.1 |
100% (80.6–100) 16/16 |
0 |
93.8% (71.7–98.9) 15/16 |
1 |
94.7% (75.4–99.1) 18/19 |
1 |
| M2 (Referable maculopathy) |
1.9 |
98.4% (95.9–99.4) 245/249 |
4 |
94.0% (90.3–96.3) 234/249 |
15 |
93.8% (90.2–96.1) 255/272 |
17 |
| R3 (Referable background retinopathy) |
0.4 |
95.8% (86.0–98.8) 46/48 |
2 |
97.9% (89.1–99.6) 47/48 |
1 |
98.0% (89.7–99.7) 50/51 |
1 |
| R4 (Proliferative retinopathy) |
0.3 |
100% (90.4–100) 36/36 |
0 |
94.4% (81.9–98.5) 34/36 |
2 |
95.2% (84.2–98.7) 40/42 |
2 |
| R6 (Technical failure) |
5.0 |
90.6% (88.1–92.6) 606/669 |
24 |
99.4% (98.5–99.8) 665/669 |
4 |
98.4% (97.4–99.0) 963/979 |
16 |